These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 25224403)

  • 1. Detection of the mechanism of immunotoxicity of cyclosporine A in murine in vitro and in vivo models.
    Schmeits PC; Schaap MM; Luijten M; van Someren E; Boorsma A; van Loveren H; Peijnenburg AA; Hendriksen PJ
    Arch Toxicol; 2015 Dec; 89(12):2325-37. PubMed ID: 25224403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of the usefulness of the murine cytotoxic T cell line CTLL-2 for immunotoxicity screening by transcriptomics.
    Schmeits PC; Volger OL; Zandvliet ET; van Loveren H; Peijnenburg AA; Hendriksen PJ
    Toxicol Lett; 2013 Feb; 217(1):1-13. PubMed ID: 23253260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunotoxicological investigation using pharmaceutical drugs. In vitro evaluation of immune effects using rodent or human immune cells.
    Lebrec H; Roger R; Blot C; Burleson GR; Bohuon C; Pallardy M
    Toxicology; 1995 Feb; 96(2):147-56. PubMed ID: 7886685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retrovirus-mediated immunosuppression. I. FeLV-UV and specific FeLV proteins alter T lymphocyte behavior by inducing hyporesponsiveness to lymphokines.
    Orosz CG; Zinn NE; Olsen RG; Mathes LE
    J Immunol; 1985 May; 134(5):3396-403. PubMed ID: 2984289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclosporine A treated in vitro models induce cholestasis response through comparison of phenotype-directed gene expression analysis of in vivo Cyclosporine A-induced cholestasis.
    Kienhuis AS; Vitins AP; Pennings JL; Pronk TE; Speksnijder EN; Roodbergen M; van Delft JH; Luijten M; van der Ven LT
    Toxicol Lett; 2013 Aug; 221(3):225-36. PubMed ID: 23830897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of cyclosporin A in Lewis rats in vivo and HeLa cells in vitro.
    Sovcikova A; Tulinska J; Kubova J; Liskova A; Syrova D; Horakova K
    J Appl Toxicol; 2002; 22(3):153-60. PubMed ID: 12015794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A pharmacologically-based array to identify targets of cyclosporine A-induced toxicity in cultured renal proximal tubule cells.
    Sarró E; Jacobs-Cachá C; Itarte E; Meseguer A
    Toxicol Appl Pharmacol; 2012 Jan; 258(2):275-87. PubMed ID: 22155090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inter-laboratory comparison of human renal proximal tubule (HK-2) transcriptome alterations due to Cyclosporine A exposure and medium exhaustion.
    Jennings P; Aydin S; Bennett J; McBride R; Weiland C; Tuite N; Gruber LN; Perco P; Gaora PO; Ellinger-Ziegelbauer H; Ahr HJ; Kooten CV; Daha MR; Prieto P; Ryan MP; Pfaller W; McMorrow T
    Toxicol In Vitro; 2009 Apr; 23(3):486-99. PubMed ID: 19159671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A modification of the in vivo mixed lymphocyte reaction and rapamycin's effect in this model.
    Warner LM; Adams LM; Chang JY; Sehgal SN
    Clin Immunol Immunopathol; 1992 Sep; 64(3):242-7. PubMed ID: 1386564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential proteomic analysis of cyclosporine A-induced toxicity in renal proximal tubule cells.
    Puigmulé M; López-Hellin J; Suñé G; Tornavaca O; Camaño S; Tejedor A; Meseguer A
    Nephrol Dial Transplant; 2009 Sep; 24(9):2672-86. PubMed ID: 19369687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leukemic cells arise from cloned cytotoxic lymphocytes during cell culture.
    Simon MM; Ali S; Tewari R; Simon HG; Müller-Hermelink HK; Epplen JT
    Eur J Immunol; 1986 Oct; 16(10):1269-76. PubMed ID: 3095125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary T-cell and activated macrophage response associated with tumor protection using peptide/poly-N-acetyl glucosamine vaccination.
    Maitre N; Brown JM; Demcheva M; Kelley JR; Lockett MA; Vournakis J; Cole DJ
    Clin Cancer Res; 1999 May; 5(5):1173-82. PubMed ID: 10353754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of action of cyclosporine A in vivo. II. T cell priming in vivo to alloantigen can be mediated by an IL-2-independent cyclosporine A-resistant pathway.
    Pereira GM; Miller JF; Shevach EM
    J Immunol; 1990 Mar; 144(6):2109-16. PubMed ID: 1968924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclosporine combined with nonlytic interleukin 2/Fc fusion protein improves immune response to hepatitis B vaccination in a mouse skin transplantation model.
    Li Z; Zhang D; Gao J; Li WX; Zhu JY
    Transplant Proc; 2013; 45(6):2559-64. PubMed ID: 23953581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppressive and enhancing effect of T-2 toxin on murine lymphocyte activation and interleukin 2 production.
    Holt PS; Corrier DE; DeLoach JR
    Immunopharmacol Immunotoxicol; 1988; 10(3):365-85. PubMed ID: 3264300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on the cytolytic attack mechanism of the cytotoxic T lymphocyte (CTL): preparation of antisera against cellfree cytosolic extracts of a CTL clone capable of blocking the lethal hit stage of CTL cytolysis and analysis of the cytolytic structure.
    Hiserodt JC
    J Immunol; 1985 Jul; 135(1):53-62. PubMed ID: 3158707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effector mechanisms of syngeneic anti-tumour responses in mice. I. Establishment and characterization of an exogenous IL-2-independent cytotoxic T-lymphocyte line specific for radiation-induced leukaemia RL male 1.
    Kuribayashi K; Keyaki A; Sakaguchi S; Masuda T
    Immunology; 1985 Sep; 56(1):127-40. PubMed ID: 3876271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The stimulation of EL-4 cells to produce interleukin-2 and its potential use in immunocytotoxicity testing.
    Lasek W; Steer S; Clothier R; Balls M
    Immunopharmacol Immunotoxicol; 1989; 11(2-3):379-96. PubMed ID: 2621323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effector mechanisms of syngeneic anti-tumour responses in mice. II. Cytotoxic T lymphocytes mediate neutralization and rejection of radiation-induced leukaemia RL male 1 in the nude mouse system.
    Keyaki A; Kuribayashi K; Sakaguchi S; Masuda T; Yamashita J; Handa H; Nakayama E
    Immunology; 1985 Sep; 56(1):141-51. PubMed ID: 3876272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble factor-independent stimulation of human B cell response by mouse thymoma cells. Cyclosporine A-resistant and -sensitive cell contact signals.
    Zhang XH; Hauser C; Zubler RH
    J Immunol; 1990 Apr; 144(8):2955-60. PubMed ID: 2139073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.